← Back to search
CHRYSALIS BIOTHERAPEUTICS, INC.
GALVESTON, TX, 77550
Unclaimed
Small Business
Prime contracting experience
2 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | DEMONSTRATE LARGE ANIMAL EFFICACY, DEFINE PROTOCOLS FOR THE PIVOTAL ANIMAL TRIAL, AND BETTER UNDERSTAND THE PHARMACODYNAMICS OF TP508. TO ACHIEVE THIS OBJECTIVE, WE WILL CONDUCT NON-CLINICAL EFFICACY SURVIVAL STUDIES IN MALE AND FEMALE MINIPIGS WITH | — | $13,030,326 | Jul 25, 2025 | Jul 1, 2019 – Feb 15, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF TP508: A NOVEL NUCLEAR COUNTERMEASURE TARGETING ENDOTHELIAL CELLS AND STEM CELLSTO COMBAT ARS AND DELAYED MULTIPLE ORGAN DYSFUNCTION | — | $6,954,509 | Apr 5, 2023 | Jan 30, 2017 – Aug 31, 2021 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced